AzTrials
AzTrials

PainNCT05425849

Pain Due to Peripheral Intravenous Catheter Insertion

A study testing rose oil aromatherapy in people with Pain, run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aimed to evaluate the effectiveness of rose oil aromatherapy and hand-holding in reducing pain associated with peripheral intravenous catheters (PIVCs) insertion. Study Hypothesis: H0-1. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Pain
What is being tested?
rose oil aromatherapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
126 participants
Where
1 siteTurkey (Türkiye)
Study dates
10 Apr 2021to 10 Sep 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • patients voluntarily accepted to participate in the study,
  • aged between 18-65,
  • Turkish literate,
  • PIVC placement planned,
  • no hematoma, ecchymosis, scar and sensory change in the antecubital region,
  • suitable for PIVC insertion with a 20 gauge (pink) catheter in the antecubital region,
Show all 9Show fewer
  • who did not take analgesic drugs for 24 hours and were accompanied by a member of the patient's family (spouse or child).
  • patients with an Enhanced Adult DIVA (EA-DIVA) score below 8 for PIVC placement in a single intervention,
  • the STAI score below 40

Who cannot join

  • sensitive to smell and had problems in smelling,
  • patients with epilepsy, asthma diagnosis,
  • patients with a history of allergy

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Tulay Basak

    Ankara, 06010

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Rose Oil Aromatherapy and Hand-Holding on Pain Due to Peripheral Intravenous Catheter Insertion: A Mixed Method Study

This study aimed to evaluate the effectiveness of rose oil aromatherapy and hand-holding in reducing pain associated with peripheral intravenous catheters (PIVCs) insertion.

Study Hypothesis:

H0-1. The application of rose oil aromatherapy during the PIVC insertion procedure does not reduce the pain associated with the procedure.

H0-2. During the PIVC insertion procedure, the patient's family holding the patient's hand does not reduce the pain associated with the procedure.

Conditions
Pain
Being tested
rose oil aromatherapy
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • rose oil aromatherapyOther

    Also called handholding

    Aromatherapy refers to the medicinal or therapeutic use of essential oils absorbed through the skin or the olfactory system. The positive effects of social support, such as hand-holding, on anxiety and pain have been described

Study groups in NCT05425849
Study groupRoleWhat they receive
control groupNo interventionNo attempt was made to reduce pain in the patients in the control group. Standard PIVC insertion procedure was applied.
rose oil groupExperimentalAfter the patients in the rose aromatherapy group were placed in a sitting position, a face mask with 1-2 drops of rose oil was placed on the nose area. Then, the standard PIVC insertion procedure was applied. After the procedure, the patient's rose-scented mask was replaced with a standard mask.
Receives: Other: rose oil aromatherapy
hand holding groupExperimentalAfter the patients in the hand-holding group were placed in a sitting position, the patient's family was asked to hold the patient's hand and not let it go until the procedure was over. Standard PIVC insertion procedure was applied.
Receives: Other: rose oil aromatherapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain Score

    Numeric Rating Scale was used. The scale is composed of 0 (no pain at all) to 10 (worst imaginable pain)

    Measured: 1 minute-10 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jun 2022
  2. Study start10 Apr 2021
  3. Primary completion10 Sep 2021
  4. Study completion10 Sep 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
126 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05425849
Sponsor's protocol ID
394
Status last verified
Jun 2022
First submitted
11 Jun 2022
Last updated
24 Jun 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Basak T, Demirtas A, Duman S. The effect of rose oil aromatherapy and hand-holding on pain due to peripheral intravenous catheter insertion. Explore (NY). 2024 Jan-Feb;20(1):62-69. doi: 10.1016/j.explore.2023.06.002. Epub 2023 Jun 7.

    PubMed 37301653

Questions about this trial

What is this clinical trial studying?

A study testing rose oil aromatherapy in people with Pain, run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain Score (time frame: 1 minute-10 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05425849, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jun 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in